Generex Biotechnology
Edit Page
Report
Scan day: 12 February 2014 UTC
28
Virus safety - good
Description: Developed a proprietary technology to administer large molecule drugs, including hormone proteins, peptides, monoclonal antibodies and vaccines as a mist absorbed in the buccal mucosa. Overview of production, aims and investor data of company in Toronto, Ontario.
Generex Biotechnology Corporation Wednesday, August 14, 2013 10:00:00 Thursday, March 28, 2013 10:00:00 Thursday, January 31, 2013 10:00:00 Thursday, October 06, 2011 15:00:00 Generex Biotechnology Corporation is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMistâ„¢ device. The Company's buccal insulin spray product, Generex Oral-lynâ„¢ is in Phase III clinical trials at several sites around the world.
Size: 828 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Generex Biotechnology Corporation |
| Keywords: | Generex Biotechnology Corporation |
| Description: | Generex Biotechnology Corporation |
| IP-address: | 208.76.228.66 |
WHOIS Info
| NS | Name Server: NS1.TCN.NET Name Server: TITAN.TCN.NET |
| WHOIS | Status: clientDeleteProhibited Status: clientRenewProhibited Status: clientTransferProhibited Status: clientUpdateProhibited |
| Date | Creation Date: 04-apr-1996 Expiration Date: 05-apr-2016 |